Concomitant (without Adjuvant) Temozolomide and Radiation to Treat Glioblastoma: a Retrospective Study

Clinical Oncology

Volumn 21, Issue 1, 2009, Pages 19-22

  Sridhar, T ^a   Gore, A ^a   Boiangiu, I ^a   Machin, D ^b   Symonds, R P ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Brain tumours; glioblastoma multiforme; radiotherapy; temozolomide

Indexed keywords

METOCLOPRAMIDE; TEMOZOLOMIDE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN SURGERY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; NAUSEA AND VOMITING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SIDE EFFECT; THROMBOCYTOPENIA; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL RATE; YOUNG ADULT;

EID: 58149161828     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.08.008     Document Type: Article

References (11)

1. Taylor R.E. Defining the standard of care for high-grade glioma - a NICE deal for patients. Clin Oncol 1 (2008) 97-98
2. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 353 (2005) 987-996
3. Walker M.D., Green S.B., Byar D.P., et al. Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Engl J Med 303 (1980) 1323-1329
4. Blamey R.W., Ellis I.O., Pinder S.E., et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 43 (2007) 1548-1555
5. Stewart L.A. Chemotherapy in adult high grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359 (2002) 1011-1018
6. Stupp R., Gander M., Leyvraz S., et al. Current and future developments in the use of temozolomide in the treatment of brain tumours. Lancet Oncol 2 (2001) 522-560
7. Hegi M.E., Disereus A.C., Gorlia T., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 (2005) 997-1003
8. Stupp R., Hegi M.E., Gilbert M.R., et al. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25 (2007) 4127-4136
9. Machin D., Cheung Y.-B., and Parmar M.K.B. Survival analysis: a practical approach. 2nd edition (2006), Wiley, Chichester
10. Athanassiou H., Synodinou M., Maragoudakis E., et al. Randomised phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 27 (2005) 2372-2377
11. Khanduri S., and Gerrad G. Defining the standard of care for high-grade glioma - a NICE deal for UK patients. Clin Oncol 19 (2007) 507-508